Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...

When the Pfizer-BioNTech COVID-19 vaccine was authorized for emergency use by the Food and Drug Administration (FDA) in December 2020, President Donald Trump referred to it as a "medical miracle." ...

A new study has found that receiving messenger RNA-based COVID-19 vaccines such as those from Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) could boost the survival rates of ...

Moderna’s mRNA-1010 showed 26.6% higher efficacy vs. standard flu shot in adults 50+. The trial enrolled 40,805 participants across 11 countries, with mild adverse reactions reported. The market’s ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.

Many New Yorkers planning to use a vaccine to protect themselves and their children from COVID-19 in 2025 now face an increasingly uncertain path to getting the shots. That warning from some doctors ...

PHILADELPHIA – Correcting misinformation after it has gone viral is a common way of informing the public that what they’ve encountered may be inaccurate, lack context, be unproven, or be demonstrably ...